Double Medical Technology Inc. (002901.SZ)
CNY 30.74
(-0.03%)
CNY 30.74
(-0.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.63 Billion CNY | 17.83% |
| 2022 | 3.93 Billion CNY | 16.5% |
| 2021 | 3.37 Billion CNY | 28.14% |
| 2020 | 2.63 Billion CNY | 17.81% |
| 2019 | 2.23 Billion CNY | 34.46% |
| 2018 | 1.66 Billion CNY | 19.93% |
| 2017 | 1.38 Billion CNY | 93.08% |
| 2016 | 719.06 Million CNY | 28.1% |
| 2015 | 561.32 Million CNY | 2.94% |
| 2014 | 545.27 Million CNY | 84.1% |
| 2013 | 296.18 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.46 Billion CNY | -0.5% |
| 2024 Q1 | 4.61 Billion CNY | -0.45% |
| 2024 Q2 | 4.48 Billion CNY | -2.94% |
| 2023 Q2 | 4.31 Billion CNY | 7.29% |
| 2023 FY | 4.63 Billion CNY | 17.83% |
| 2023 Q4 | 4.63 Billion CNY | 3.04% |
| 2023 Q3 | 4.5 Billion CNY | 4.35% |
| 2023 Q1 | 4.02 Billion CNY | 2.14% |
| 2022 Q2 | 3.86 Billion CNY | 0.49% |
| 2022 Q1 | 3.84 Billion CNY | 13.74% |
| 2022 FY | 3.93 Billion CNY | 16.5% |
| 2022 Q4 | 3.93 Billion CNY | -0.25% |
| 2022 Q3 | 3.94 Billion CNY | 2.18% |
| 2021 Q2 | 2.86 Billion CNY | 4.48% |
| 2021 Q3 | 2.98 Billion CNY | 4.15% |
| 2021 Q4 | 3.37 Billion CNY | 13.16% |
| 2021 Q1 | 2.74 Billion CNY | 4.06% |
| 2021 FY | 3.37 Billion CNY | 28.14% |
| 2020 Q4 | 2.63 Billion CNY | 9.16% |
| 2020 FY | 2.63 Billion CNY | 17.81% |
| 2020 Q1 | 2.26 Billion CNY | 1.23% |
| 2020 Q2 | 2.49 Billion CNY | 10.19% |
| 2020 Q3 | 2.41 Billion CNY | -3.24% |
| 2019 FY | 2.23 Billion CNY | 34.46% |
| 2019 Q4 | 2.23 Billion CNY | 11.99% |
| 2019 Q3 | 1.99 Billion CNY | 12.77% |
| 2019 Q2 | 1.77 Billion CNY | 1.04% |
| 2019 Q1 | 1.75 Billion CNY | 5.36% |
| 2018 Q2 | 1.41 Billion CNY | -1.88% |
| 2018 FY | 1.66 Billion CNY | 19.93% |
| 2018 Q4 | 1.66 Billion CNY | 8.34% |
| 2018 Q3 | 1.53 Billion CNY | 8.67% |
| 2018 Q1 | 1.44 Billion CNY | 3.81% |
| 2017 Q4 | 1.38 Billion CNY | 8.3% |
| 2017 FY | 1.38 Billion CNY | 93.08% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 747.85 Million CNY | 0.0% |
| 2017 Q3 | 1.28 Billion CNY | 71.42% |
| 2016 FY | 719.06 Million CNY | 28.1% |
| 2016 Q4 | 719.06 Million CNY | 0.0% |
| 2015 FY | 561.32 Million CNY | 2.94% |
| 2014 FY | 545.27 Million CNY | 84.1% |
| 2013 FY | 296.18 Million CNY | 0.0% |